Class II Recall

Pfizer Inc.

Product
Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Reason
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Classification
Class II
Status
Terminated
Lot
Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Pfizer Inc. — Class II Recall | MedicineWatch US